Dextran is a polysaccharide used in hematological drugs, primarily as a plasma expander. It is used to treat conditions such as hypovolemia, anemia, and thrombocytopenia. It is also used to reduce the risk of blood transfusions and to reduce the risk of complications from surgery. Dextran is available in a variety of formulations, including intravenous, intramuscular, and oral. The dextran market is a growing segment of the hematological drugs market. It is used in a variety of medical applications, including the treatment of anemia, thrombocytopenia, and hypovolemia. It is also used to reduce the risk of blood transfusions and to reduce the risk of complications from surgery. Some of the companies in the dextran market include Baxter International, Fresenius Kabi, B. Braun Melsungen AG, Grifols, and Octapharma. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
